Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘James E. Flynn’

stock, market, buy, graph, risk, trading, dice, concepts, chart, objects, investment, opportunity, business, three-dimensional, horizontal, line, gambling, decisions, symbol,

Hedge Fund and Insider Trading News: Stanley Druckenmiller, David Tepper, Constellation Pharmaceuticals Inc (CNST), BIOLASE Inc (BIOL), Novocure Ltd (NVCR), and a Lot More

Billionaires Druckenmiller, Soros Throw Weight Behind Oil Rally (Bloomberg) The recovery in the oil industry is attracting some of the most recognized......(read more)
Peter Kolchinsky

Five Stocks To Buy According To Top Biotech-Focused Funds

Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: James E. Flynn and Homology Medicines Inc (FIXX)

Homology Medicines Inc (NASDAQ:FIXX): James E. Flynn filed an amended 13D. You can check out Deerfield Management’s latest holdings and filings......(read more)
Quickest and Easiest Masters Degrees to Get Online

13D Filing: James E. Flynn and DFB Healthcare Acquisitions Corp.

DFB Healthcare Acquisitions Corp.: James E. Flynn filed an amended 13D. You can check out Deerfield Management’s latest holdings and filings here......(read more)
25 Most Expensive Countries in the World in 2017

13D Filing: James E. Flynn and DFB Healthcare Acquisitions Corp.

DFB Healthcare Acquisitions Corp.: James E. Flynn filed an amended 13D. You can check out Deerfield Management’s latest holdings and filings here......(read more)
Countries With Highest Medical Research Spending

13G Filing: James E. Flynn and Natera Inc. (NTRA)

Natera Inc. (NASDAQ:NTRA): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
Copyright: nexusplexus / 123RF Stock Photo

13D Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

Proteon Therapeutics Inc (NASDAQ:PRTO): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’......(read more)
Pressmaster/Shutterstock.com

13D Filing: James E. Flynn and AveXis Inc (AVXS)

AveXis Inc (NASDAQ:AVXS): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

13G Filing: James E. Flynn and Mallinckrodt PLC (MNK)

Mallinckrodt PLC (NYSE:MNK): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

13G Filing: James E. Flynn and Lannett Co Inc (LCI)

Lannett Co Inc (NYSE:LCI): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
biotech research company, bio-technology companies

13G Filing: James E. Flynn and Aclaris Therapeutics Inc (ACRS)

Aclaris Therapeutics Inc (NASDAQ:ACRS): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’......(read more)
Pressmaster/Shutterstock.com

13D Filing: James E. Flynn and AveXis Inc (AVXS)

AveXis Inc (NASDAQ:AVXS): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
Sergey Nivens/Shutterstock.com

13G Filing: James E. Flynn and Mirna Therapeutics Inc. (MIRN)

Mirna Therapeutics Inc. (NASDAQ:MIRN): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’......(read more)
Easiest Md/PhD Programs to Get Into

13G Filing: James E. Flynn and Neos Therapeutics Inc (NEOS)

Neos Therapeutics Inc (NASDAQ:NEOS): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s......(read more)
biotech research company, bio-technology companies

13G Filing: James E. Flynn and Ardelyx Inc. (ARDX)

Ardelyx Inc (NASDAQ:ARDX): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
Pressmaster/Shutterstock.com

13D Filing: James E. Flynn and AveXis Inc (AVXS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
biotech research company, bio-technology companies

13D Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
30 Funniest Science Jokes, Puns, and Humor Quotes Ever

13D Filing: James E. Flynn and Alpine Immune Sciences Inc. (ALPN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 20 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Alpine Immune Sciences Inc. (ALPN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13G Filing: James E. Flynn and Marinus Pharmaceuticals Inc (MRNS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and AveXis Inc (AVXS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Adeptus Health Inc. (ADPT)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Ehealth Inc. (EHTH)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 19 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Audentes Therapeutics Inc (BOLD)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 18 – SEC Filing   SECURITIES AND EXCHANGE COMMISSION......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Nivalis Therapeutics Inc. (NVLS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 16 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Adeptus Health Inc. (ADPT)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 8 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Mannkind Corp (MNKD)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing   SECURITIES AND EXCHANGE COMMISSION......(read more)
James Flynn Deerfield Management

Blueprint Medicines Corp (BPMC) Stock: Deerfield Management Reports New 4.51% Stake

A new 13G filing with the Securities and Exchange Commission revealed that James E. Flynn‘s Deerfield Management has acquired 1.23 million common......(read more)
pharmaceuticals-385956_1280

5 Stocks That Healthcare Fund Deerfield Management Was Buying in Q2

Founded by James E. Flynn in 2000, Deerfield Management has grown to become one of the premier healthcare-focused investment management companies today......(read more)
Paul Singer ELLIOTT MANAGEMENT

Billionaire Singer Lifts Stake in Cabelas Inc. (CAB), Deerfield Bets on Beloranib, Plus Two Other Moves

Numerous closely-watched hedge fund vehicles are currently disclosing their equity positions as of the end of 2015, so individual investors can monitor......(read more)
James Flynn Deerfield Management

Billionaires James Flynn, David Abrams, Among the Elite Investors Buying These 4 Stocks Last Week

Individual investors might find hedge fund investing quite expensive, considering the 2-and-2o fee structure most hedge funds employ. However, mimicking......(read more)
Keith Meister, Corvex Capital

A Look At Smart Money Three Latest Moves

In new filings with the U.S. Securities and Exchange Commission, Kelly Cardwell’s Central Square Management, James E. Flynn’s Deerfield Management......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Smart Money Is Seeing Upside For These Three Companies

Three companies have recently been the subject of bullish moves by hedge funds. Let us take a look at what makes these companies seem undervalued to hedgies......(read more)
TIGER GLOBAL Investor Letter

Tiger Global Cuts Stake in Autohome, While Deerfield Buys More Shares of This Pharmaceutical Company

Federal funds future contracts suggest a 79% probability that the Federal Reserve will raise interest rates at the December policy meeting, an event which......(read more)
HIGHBRIDGE CAPITAL MANAGEMENT

Elite Hedge Funds Make Big Moves In These 3 Healthcare Stocks

A Schedule 13G is a public filing that must be submitted with the SEC by every hedge fund manager or other investor who acquires ownership of more than......(read more)
James Flynn Deerfield Management

Elite Hedge Funds Believe These Two Stocks Are Golden Opportunities

There are not many signals at the moment that suggest a continuation of the so-called “correction”, except for the potential letdown of the current......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Three Healthcare Stocks Hedge Funds Are Snapping Up

Is it a good time to buy Alimera Sciences Inc (NASDAQ:ALIM)? James E. Flynn thinks so, having recently acquired 321,784 shares of the pharmaceutical......(read more)
James Flynn Deerfield Management

Hedge Funds’ Make Moves On Newly-Public Biotech And “Undervalued” Broker

The U.S equities markets have seriously pulled back lately, so hedge funds and other investors are stumbling upon a greater number of quality investing......(read more)
James Flynn Deerfield Management

Two Stocks That Have Deerfield Management And Anchor Bolt Capital Excited

In a recent filing with the Securities and Exchange Commission (SEC), James E. Flynn (pictured) has revealed his latest play: Akari Therapeutics PLC (......(read more)
James Flynn Deerfield Management

Deerfield Management Discloses 3.66% Stake In Newly Public Company Global Blood Therapeutics Inc. (GBT)

James E. Flynn’s Deerfield Management has filed a Schedule 13G disclosing a 3.66% ownership stake in the newly public company Global Blood Therapeutics......(read more)
James Flynn Deerfield Management

Deerfield Management Buys More And More Imprivata Inc. (IMPR) Shares

James E. Flynn’s Deerfield Management has filed a 13G with the U.S. Securities and Exchange Commission regarding its ownership of shares of Imprivata......(read more)
James Flynn Deerfield Management

James Flynn’s Deerfield Management Ups Its Stake In Neos Therapeutics Inc. (NEOS)

James E. Flynn’s Deerfield Management disclosed that it has upped its position in Neos Therapeutics Inc. (NASDAQ:NEOS) by 545,833 shares since the fund......(read more)
Neos Therapeutics

Deerfield Management Discloses Stake In Recently Public Neos Therapeutics Inc (NEOS)

Constantly on the hunt for biotechnology stocks, James E. Flynn has identified another potential winner. In a recent Form 3 filing with the Securities......(read more)
healthcare

Deerfield Management Ups Passive Stake In Streamline Health Solutions Inc. (STRM) To 12.18%

Deerfield Management, led by James E. Flynn, has increased its stake in Streamline Health Solutions Inc. (NASDAQ:STRM). In a newly-amended 13G filing......(read more)
active-84646_1280

Does James Flynn Think the Entry Point For Healthways, Inc. (HWAY) Has Arrived, And Should You Enter?

According to a recent filing with the Securities and Exchange Commission, James E. Flynn‘s Deerfield Management has acquired about 2.47 million......(read more)
CITADEL INVESTMENT GROUP

Ken Griffin And James Flynn Are Not Wasting Any Time Getting In On These New IPOs

Ken Griffin‘s (pictured) Citadel Investment Group has acquired about 1.09 million shares of 8Point3 Energy Partners LP (NASDAQ:CAFD). The holding......(read more)